The FDA approved a label update for Winrevair to include that it lowers the risk for clinical worsening events in adults with ...
Sotatercept-csrk is approved for improving exercise capacity and reducing clinical worsening in PAH patients, following FDA ...
WINREVAIR is the subject of a licensing agreement with Bristol Myers Squibb.
Rahway, New Jersey Tuesday, October 28, 2025, 12:00 Hrs [IST] ...
Achieves full-year records in sales, operating margin and cash generation GALWAY, Ireland, Oct. 29, 2025 /PRNewswire/ -- TE ...
The gastroparesis market is poised for significant growth, driven by the emergence of novel therapeutic classes such as the Dopamine D2 receptor antagonist (GIMOTI). Meanwhile, novel therapies like ...
Verizon Communications Inc. ( VZ) Q3 2025 Earnings Call October 29, 2025 8:30 AM EDT Good morning, and welcome to Verizon's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Today's ...
Compare Bank of America Corporation BAC.PR.N and BAC.PR.Q preferred stocks for yield and call protection. Click for better ...
Operating expenses amounted to $107.0 million for the nine months ended September 30, 2025, compared with $96.4 million for the nine months ended September 30, 2024, an increase by $10.6 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback